EU-JAV Sixth Newsletter
31 March 2022
Welcome to the sixth JAV newsletter!
Welcome to the sixth JAV newsletter!
Dear EU-JAV Partners,
For your information, on 4 March 2022, HaDEA ( European Health and Digital Executive Agency) published a call for tenders, by means of which the Commission wants to support Member States in their decision-making on national vaccination plans, including COVID-19 vaccines and any adaptations of those vaccines due to the emergence of SARS-CoV-2 variants.
The European Joint Action on Vaccination (EU-JAV), co-funded by EU’s Health Program and the European Health and Digital Executive Agency (HaDEA), is pleased to inform you of its final conference.
For your information, on 21 February 2022, HaDEA ( European Health and Digital Executive Agency) published a call for tenders, by means of which the Commission wants to support Member States in monitoring the performance of national vaccination programmes and services
WP4 team has written an article for The Lancet that describes their work within the EU-JAV.
Service Contract to Identify Obstacles to Vaccination of Physical, Practical or Administrative Nature and Develop Recommendations Dear EU-JAV Partners, For your information, on 11 January 2022, HaDEA ( European Health and Digital Executive Agency) published a call for tenders, by means of which the Commission wants to explore to what extent physical obstacles to vaccination has […]
On February 14th, the EU-JAV WP8 team held a the webinar on the EU Health Policy Platform:
“Vaccine hesitancy and uptake. From research and practices to implementation”
WP7 team has written an article for the scientific magazine ‘Vaccine’ that describes their work within the EU-JAV.
Last week on 24 and 26 November, the Swedish Public Health Agency hosted 2 digital workshops to discuss cross border vaccination campaigns.
WP8 team has written an article for the Italian scientific journal ‘Bollettino Epidemiologico Nazionale’ that describes their work within the EU-JAV.